Pharmafile Logo

Crucell

AstraZeneca AZ

AstraZeneca joins Merck in Brexit stockpiling effort

Says it is increasing stores of medicines by around 20%

- PMLiVE

Brexit rebels win vote on European Medicines Agency alignment

EMA membership will be a key negotiating aim; Sir John Bell sees independent MHRA post-Brexit

- PMLiVE

‘Common Rulebook’ Brexit plans include medicines – but face backlash

Government compromises could be opposed from both sides

- PMLiVE

May’s Brexit plan cautiously welcomed by biopharma sector

The white paper says the UK should adhere to EMA regulations post-Brexit

- PMLiVE

Some pharma companies not prepared for Brexit, warns EMA

Regulator concerned about medicines shortages after March 2019

- PMLiVE

‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

Training the next generation of biotech leaders

Blue Latitude Health speaks to Dr Ivan Wall, Reader in Cell & Gene Therapy Bioprocessing at University College London, to find out about the future of cell and gene therapy,...

Blue Latitude Health

- PMLiVE

Daily Brief: Crunch time for Brexit, GSK CEO RSVP from Trump

A round up from pharma, biotech and healthcare

- PMLiVE

NHS bracing for ‘no deal’ Brexit impact, including medicines

Simon Stevens says plans well advanced for shock to supply chain

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links